— Know what they know.
Not Investment Advice

ENGN NASDAQ

enGene Holdings Inc.
1W: -7.2% 1M: -21.3% 3M: -13.4% YTD: -82.5% 1Y: -81.3%
$1.55
-0.03 (-1.90%)
 
Weekly Expected Move ±8.1%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 24 · $103.9M mcap · 25M float · 3.40% daily turnover · Short 38% of daily vol
Credit Risk of going bust: higher than 96% of companies Debt: 24.3% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.14 (down 91%), enGene Holdings Inc. would be worth roughly what it owes.
Total debt $33.3M against a stock market value of $103.9M.
Distance to default 0.40 (Merton model): prices to 2026-10-27, balance sheet 2026-07-31, debt counted $15.0M (short-term plus half of long-term), stock volatility 182.8%; Altman Z'' 1.53. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2025-06-09
Earliest Filing
2025-06-09
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named ENGN in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
ENGNW enGene Holdings Inc. partner Parent company and guarantor of the lease obligations for enGene USA, Inc. 2025-06-09 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-08 Earnings Release; Exhibits View
2026-08-11 Other Events; Exhibits View
2026-07-17 Regulation FD; Exhibits View
2026-07-16 Officer/Director Change; Regulation FD; Exhibits View
2026-06-18 Exit/Disposal Costs; Officer/Director Change View
2026-06-15 Earnings Release; Exit/Disposal Costs; Officer/Director Change; Regulation FD; Other Events; Exhibit View
2026-06-10 Shareholder Vote; Exhibits View
2026-05-07 Officer/Director Change; Regulation FD; Other Events; Exhibits View
2026-04-09 Bylaws Amendment; Regulation FD; Exhibits View
2026-03-09 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-03-09 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Financial St Agreement View
2026-01-21 Regulation FD Disclosure; Financial Statements and Exhibits View
2026-01-21 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2025-12-22 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-14 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-11-12 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-10-02 Departure/Election of Directors; Appointment of Officers View
2025-10-02 Departure/Election of Directors; Appointment of Officers View
2025-09-30 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-09-11 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms